SPX4,300.97+3.83 0.09%
DIA341.29+1.92 0.57%
IXIC13,084.38-43.68 -0.33%

Spain's Grifols first-half net profit falls 46% dragged by costs of acquisitions

Spain's Grifols first-half net profit falls 46% dragged by costs of acquisitions

Reuters · 07/28/2022 02:53
Spain's Grifols first-half profit falls 46% dragged by costs of acquisitions

- Spanish pharmaceutical company Grifols GRFS said on Thursday its first-half profit fell 46% year-on-year to 143.6 million euros ($146.80 million) due to the higher financial impact of asset acquisitions even though revenues and plasma collection grew.

Grifols, which uses blood plasma to make medicines, said its revenues increased 11% to 2.8 billion euros thanks to a positive performance of its biopharma department and a 22% increase in plasma collections, a trend it expects will accelerate in the second half of 2022.

($1 = 0.9782 euros)


(Reporting by Joan Faus, editing by Inti Landauro)

((joan.faus@thomsonreuters.com;))